Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Nov;18(6):667-70.
doi: 10.1097/01.cco.0000245318.90015.72.

Differences between the different conditioning regimens for allogeneic stem cell transplantation

Affiliations
Review

Differences between the different conditioning regimens for allogeneic stem cell transplantation

Anton V M B Schattenberg et al. Curr Opin Oncol. 2006 Nov.

Abstract

Purpose of review: The aim of this article is to compare the differences in efficacy and toxicity between the various conditioning regimens for allogeneic stem cell transplantation.

Recent findings: Several studies, all retrospective, that compare the impact of various different conditioning regimens amongst each other are presented. Reduced intensity conditioning apparently lowered transplant-related mortality in patients with minimal residual disease who were at high risk for treatment-related mortality. In contrast, patients with active disease could only be salvaged when a myeloablative conditioning regimen was used. By consequence, it was concluded that patients without contraindications for a myeloablative conditioning regimen should not receive reduced regimens outside a prospective randomized trial.

Summary: Despite high expectations, non-myeloablative conditioning regimens and regimens that have been reduced in intensity did not prove to be superior in survival when the outcomes were compared with those obtained with conventional myeloablative conditioning. Randomized prospective studies are needed to explore the appropriate niche for the various different regimens.

PubMed Disclaimer

MeSH terms